Two probiotic strains “GM-080” and “GMNL-33,” developed and marketed by GenMont Biotech Inc., (TWOTC: 3164) have been approved by regulatory agencies in China, and can now be used as additive ingredients to food products in that market. More
At a forum focusing on allergy causes and treatment strategies held in Taipei, botanically-derived health products company Medigreen Biotechnology unveiled its new anti-allergy formulation More
The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More
Integrated to the new production plant is a centre for distribution and logistics, sales and administration. The new plant is also the first B. Braun Excellence Center for the manufacture of enteral diets worldwide. More
Dr. Paul Adams, a researcher at Lawson Health Research Institute (Lawson) along with other colleagues have made the unexpected discovery that individuals who develop hemochromatosis have lower total and low-density lipopr More
Encap, the international drug delivery solutions provider, has strengthened its Board of Directors and appointed Dr Stephen Brown as R&D Director with immediate effect. More
Encap, the international drug delivery solutions provider, announced that Dr Joe Carey has been appointed as the new Chief Executive Officer effective today. More
Encap, the international drug delivery solutions provider, has announced that it has relocated to a larger purpose-built site at Oakbank Park Way, Livingston, Scotland. More
Encap, the international drug delivery solutions provider, announced today that it has signed a Head of Terms with Kenmore Capital Oakbank Ltd and secured a long-term lease for a new 14,000 sq. ft facility at Oakbank Park Way, Livingston, Scotland. More
All rights reserved. Terms and Conditions | Contact us
